The Chronicle of Higher Education

In Brief

INVENTION WINDFALL: In what could be the biggest windfall of its kind to date, Northwestern University has received $700-million for selling some of its rights to future royalties from a new blockbuster drug. The drug, marketed under the name Lyrica, is used to treat pain associated with fibromyalgia, shingles, and diabetes. A portion of the payment will go to the inventor, Richard B. Silverman, a...

To continue reading this premium article, you must have a Chronicle account AND a subscription or an online pass.

Subscriptions start at $40; Web passes for under $10.